History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

Dont bother about gemfinder !! If you want to make him suffer, just go short hengyuan~~ trust he already bought in the counter today!! He might jump off a building tomorrow~~

History always had the tendency to repeat itself !!

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

History always had the tendency to repeat itself !! Tomorrow is panicky day AND with RSS in play, someone might get heart attack ~~

Possible MCO and bonus exdate tomorrow !! Expect total chaos on Wednesday onward~~

Out of sudden so many experts !! What is their motivation ?? If I have a tip or an indication, I will will hold it tight and keep it to myelf instead of telling everyone else so that they all can capatalise, right !! Just to talk cock here !!

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 10% for FY21 with the current price

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 10% for FY21 with the current price

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

https://www.usatoday.com/story/news/health/2021/01/06/death-florida-doctor-following-pfizer-covid-19-vaccine-under-investigation-gregory-michael/6574414002/

Vaccine Death ~~ Buying own coffin ??

You know UK is the first country got vaccinated. Trust they are the most vaccinated country now. The big question now is why are their covid 19 number still increasing ?
This will lead to further questions:-
Is the covid variant change so much that the vaccine is rander ineffective ? Do we need to develop new vaccine for this covid variant ? Is the current vaccine purchased by the government still needed ? Do we have the covid variant ? Are we ready to tackle this issues ? When will the pandemic end ?

Not to pour cold water on the hopeful but you guys just need to see the whole picture than be one sided !! In the end, there is a reason why WHO or the US FDA approve it as emergency use THAN an official use. In addition, the trial data submitted is all from the manufacturer itself and we all know how a profitable manufacturer will do whatever its take to defend their product !!

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 10% for FY21 with the current price

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

High Dividend !!
Record Breaking Revenue !!
Record Breaking Profit !!
Order in hand for the whole year !!
Glove demand to rise monthly for the whole year !!
ASP to spiked until first half of the year !!
High Cash in hand !!
Sukuk financial back up !!

What more do you want ?? All the good indicators for a matched

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

Lets talk about US glove stockpile :- It has dropped from 16.9 millions at the beginning of the year to 2 millions in dec 2020 !! They will replenish it once Biden resume its presidential role !! Look forward for the Orders and Higher ASP !!

https://www.cbsnews.com/news/nitrile-glove-shortage-covid-19-vaccine-60-minutes-2020-12-06/

Not to pour cold water on the hopeful but you guys just need to see the whole picture than be one sided !! In the end, there is a reason why WHO or the US FDA approve it as emergency use THAN an official use. In addition, the trial data submitted is all from the manufacturer itself and we all know how a profitable manufacturer will do whatever its take to defend their product !!

Vaccine death :-

https://www.usatoday.com/story/news/health/2021/01/06/death-florida-doctor-following-pfizer-covid-19-vaccine-under-investigation-gregory-michael/6574414002/

https://www.cnn.com/2021/01/06/health/coronavirus-vaccine-doctor-death/index.html

Are we buying our own coffin ?

You know UK is the first country got vaccinated. Trust they are the most vaccinated country now. The big question now is why are their covid 19 number still increasing ?
This will lead to further questions:-
Is the covid variant change so much that the vaccine is rander ineffective ? Do we need to develop new vaccine for this covid variant ? Is the current vaccine purchased by the government still needed ? Do we have the covid variant ? Are we ready to tackle this issues ? When will the pandemic end ?

Dont worry about gemfinder !! He is just a O&G supporter !! If You really want him to suffer ... just go short on heng yuan counter !! He will cry and maybe jump off the building ~~ wakaka

Political uncertainy will only create extra panic in recovery market especially construction and bank !! Welcome to all crossed buying kaki !!

Possible MCO, Possible change of goverment, Possible Vaccine side effect & death!! So much uncertainy !! But one thing is certain is Covid is rising and Glove is in high demand !!

The vaccine came and the pandemic is over theme doesnt look that good anymore!! Right ??
Which sector do you think will thrive the most in this situation ??

Another question!! Last two days in the US there is a death reported due to vacination !! How is that possible after all the trial had been done ?? Did the manufacturer trying to cover up their mistake or faulty products??

One quick question !!
Since UK is the first vaccinated country and they are the one who got the most vacinated !! Then why their case still spike and they are still in a lockdown ??
Give it a thought !! Is the vaccine really that efficient?? Is the covid variant had change so much which had rander the vaccine useless??

Vaccination expected to get 50% of the population at te end of this year or early next year !! The ASP which risen at 30% this quarter expected to maintain to next quarter due to high demand of gloves!!
Not forgeting the potential side effect of vaccine which may rander it to be useless especially with the new covid variant !!
RM 2.4 + RM 3.2 + RM 3.2 + RM 2.4 = RM 11 B PAT FY 21

ASP to rised at 30% and higher capacity 5%
Last QTR PAT = RM 2.4 B X +30% X +5% = RM3.276 B PAT next quarter !! Pls be reminded !!

Compound Interest on Monday and MCO only lead to bullish run on Monday again !!

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

High Dividend !!
Record Breaking Revenue !!
Record Breaking Profit !!
Order in hand for the whole year !!
Glove demand to rise monthly for the whole year !!
ASP to spiked until first half of the year !!
High Cash in hand !!
Sukuk financial back up !!

What more do you want ?? All the good indicators for a matched

Learned from experience :-
Lockdown = business suspended = revenue slow down = economy slow down = bank no transaction !!

Recovery market sure get RSS kaw kaw Monday!!

While essential products like food, medical and PPE thrived !!

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 8% for FY21 with the current price

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

If vaccine so effective then why UK still lockdown ??